Published in
Springer, Journal of Neuro-Oncology, 3(147), p. 577-585, 2020
DOI: 10.1007/s11060-020-03470-3
Links
Tools
GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma
Journal article published in 2020 by
Sascha Marx 
,
Fabian Wilken,
Isabel Wagner,
Madlen Marx ,
Sascha Troschke-Meurer ,
Maxi Zumpe ,
Sandra Bien-Moeller,
Martin Weidemeier,
Joerg Baldauf,
Steffen K. Fleck,
Bernhard H. Rauch,
Henry W. S. Schroeder,
Holger Lode ,
Nikolai Siebert
,
Fabian Wilken,
Isabel Wagner,
Madlen Marx ,
Sascha Troschke-Meurer ,
Maxi Zumpe ,
Sandra Bien-Moeller,
Martin Weidemeier,
Joerg Baldauf,
Steffen K. Fleck,
Bernhard H. Rauch,
Henry W. S. Schroeder,
Holger Lode ,
Nikolai Siebert
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 